CompLement C5 Antibodies for decreasing brain injury after aneurysmal Subarachnoid Haemorrhage (CLASH): study protocol for a randomised controlled phase II clinical trial

BACKGROUND: The inflammatory response after aneurysmal subarachnoid haemorrhage (aSAH) has been associated with early brain injury, delayed cerebral ischaemia, poor functional outcome, and case fatality. In experimental SAH studies, complement C5 antibodies administered shortly after SAH reduced bra...

Descripción completa

Detalles Bibliográficos
Autores principales: Koopman, Inez, Rinkel, Gabriel J. E., Vergouwen, Mervyn D. I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687754/
https://www.ncbi.nlm.nih.gov/pubmed/33239044
http://dx.doi.org/10.1186/s13063-020-04838-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687754/
https://www.ncbi.nlm.nih.gov/pubmed/33239044
http://dx.doi.org/10.1186/s13063-020-04838-6

Ejemplares similares